Terapeutas, MB - financials and debts

Company age: 5 y. 6 mo.

Update

Terapeutas - Company finances

EUR
2021
From: 2021-04-06
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 3,766 3,862 4,383 4,366 5,326
Profit before tax 805 135 432 414 774
Net profit 759 128 410 393 728
Equity 859 100 547 540 868
Liabilities - 78 202 301 412
Non-current assets 0 0 0 0 0
Current assets 955 315 749 841 1,280
Total assets 955 315 749 841 1,280
Taxes paid
STI taxes - - 7 22 21
Financial indicators
Revenue change y/y - +2.5% +13.5% -0.4% +22.0%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 79.5% 40.6% 54.7% 46.7% 56.9%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 88.4% 128.0% 75.0% 72.8% 83.9%
Profit margin Net profit margin. Shows the overall profitability of the company. 20.2% 3.3% 9.4% 9.0% 13.7%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 21.4% 3.5% 9.9% 9.5% 14.5%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. - 0.8 0.4 0.6 0.5
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. - - - - -

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Terapeutas - Social security debts

The company had no debts to Sodra

Terapeutas - VMI tax arrears

The company had no tax arrears (debts) to the State Tax Inspectorate

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Terapeutas, MB (code 305719166) is a Small partnership engaged in dental practice care activities. In 2025, the latest year, it generated revenue of €5.3K, up 22.0% year on year and 21.5% over two years. Net profit increased to €728, and the profit margin improved to 13.7% from 9.0% in 2024 and 9.4% in 2023. The three-year trend shows stable sales of about €4.4K in 2023 and 2024, followed by a stronger advance in 2025, while profitability expanded more quickly than turnover. The balance sheet also grew gradually: total assets rose from €749 in 2023 to €841 in 2024 and €1.3K in 2025. Equity increased to €868, while liabilities reached €412. The equity ratio was 67.8% and debt-to-equity stood at 0.47, indicating a relatively conservative funding structure. Asset turnover reached 4.16x, showing efficient use of a small asset base. Returns on equity and assets were elevated in 2025, reflecting both higher profit and the company’s limited capital base.